Sort   by:  
 Page size 
Systematic discovery of CRISPR-boosted CAR T cell immunotherapies
Repurposing CD19-directed immunotherapies for pediatric t(8 21) acute myeloid leukemia
Inhibition of PARP11 inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapies.
Sort   by:  
 Page size